Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy using a LIV1-ADC and a chemotherapeutic

Combination therapy using a LIV1-ADC and a chemotherapeutic

US Patent 11325980 · Granted May 10, 2022

Estimated economic value: $215,036,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Goblet2025
Methods for reducing eosinophilic infiltration by administering an anti-interleu2025
Fiber-optical sensor system for ultrasound sensing and imaging2024
Cysteine mutated antibodies for conjugation2024
BCMA antibodies and use of same to treat cancer and immunological disorders2023
Methods of treating eosinophilic esophagitis by administering an antibody which 2022
Anti-NTB-A antibodies and related compositions and methods2022
Method of treating an allergy with allergen-specific monoclonal antibodies2022
Methods and compositions for making antibodies and antibody derivatives with red2022
Humanized antibodies to LIV-1 and use of same to treat cancer2022
BCMA antibodies and use of same to treat cancer and immunological disorders2021
CD123 antibodies and conjugates thereof2021